Companies: 10,795·Total market cap: $144.5T
Health Sciences Group, Inc.

Health Sciences Group, Inc.

HESGOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1870936
P/E Ratio
52W High$0.0001
52W Low$0.000001
Overview

Health Sciences Group, Inc. (HESG) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

hesg · pe ratio · data through Dec 31, 2012

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Health Sciences Group, Inc. (HESG) measures how much investors pay for each dollar of the company's trailing earnings. HESG's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.03.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2012-12-31

Forward P/E
N/A
EPS (TTM)
-$0.03
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Health Sciences Group, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-15

PE Ratio History

2000 – 2012 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Health Sciences Group, Inc.
Health Sciences Group, Inc.You
HESG
$2MN/A-$0.03
America Great Health
America Great Health
AAGH
$4MN/A-$0.00
Ayala Pharmaceuticals, Inc.
Ayala Pharmaceuticals, Inc.
ADXS
$26MN/A-$7.99
Agentix Corp.
Agentix Corp.
AGTX
$1MN/A-$0.01
EVIO, Inc.
EVIO, Inc.
EVIO
$1M3.34x+99.1%$0.00
Galera Therapeutics, Inc.
Galera Therapeutics, Inc.
GRTX
$7M0.01x-99.1%$1.51
Universal Ibogaine Inc.
Universal Ibogaine Inc.
IBOGF
$7MN/A-$0.06
Industry Average
2 peers with valid PE
1.68xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 7 of 7 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2012-12-31Latest
FY2012
$-0.03
2005-12-31
FY2005
$-0.23
2004-12-31
FY2004
$-0.74
2003-12-31
FY2003
$-0.67
2002-12-31
FY2002
$-0.73
2001-12-31
FY2001
$-0.22
2000-12-31
FY2000
$-0.02

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Health Sciences Group, Inc. (HESG) measures how much investors pay for each dollar of the company's trailing earnings. HESG's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.03.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.03 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

HESG pe ratio · 6 questions

HESG's current PE ratio is N/A as of 2026-06-15, based on a stock price of $0.00 and TTM EPS of -$0.03. Data sourced from Financial Modeling Prep via HESG's SEC 10-K and 10-Q filings.

HESG PE ratioWhat is HESG PE ratioCurrent PE ratio of HESGHESG PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Health Sciences Group, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-15